Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 2 - 10 | 2024 | $370,000,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 10 - 50 | 2024 | $400,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end | San Francisco | CA | 50 - 100 | 2024 | $1,000,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the str | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 1 - 10 | 2024 | $500,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 10 - 50 | 2024 | $325,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machi | Irvine | CA | 5 - 10 | 2024 | $3,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 2 - 10 | 2024 | $100,000,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 1 - 10 | 2024 | $16,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 10 - 50 | 2024 | $48,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free f | San Francisco | CA | 1 - 10 | 2024 | $30,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 2 - 10 | 2024 | $92,000,000 |
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 2 - 10 | 2023 | $5,200,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolo | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 1 - 10 | 2023 | $7,078,494 |
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 1 - 10 | 2023 | $500,000 |
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologic | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 1 - 10 | 2023 | |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to- | San Francisco | CA | 10 - 50 | 2023 | $245,000,000 |
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 2 - 10 | 2023 | $10,000,000 |
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 100 | 2023 | $4,175,000 |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 2 - 10 | 2023 | $6,000,000 |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory | San Francisco | CA | 10 - 50 | 2023 | $16,000,011 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 200 | 2023 | $14,999,999 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 10 - 50 | 2023 | $178,000,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to u | New York | NY | 10 - 50 | 2023 | $142,000,000 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 1 - 10 | 2023 | $13,039,726 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 10 - 50 | 2023 | $4,000,000 |
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical developmen | Gainesville | FL | 20 - 50 | 2023 | $36,000,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 200 - 500 | 2023 | $8,514,671 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 20 - 100 | 2023 | $360,000,000 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 1 - 10 | 2023 | $500,000 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch | Bedford | MA | 10 - 50 | 2023 | $20,000,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, | Fremont | CA | 20 - 50 | 2023 | $165,000,000 |
Ryne Biotechnology focuses on developing therapies for neurodegenerative movement disorders. The company was founded in 2022 and is headquartered in Cambridge, Massachusetts, United States. | San Diego | CA | 5 - 10 | 2022 | $89,000,000 |
Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificia | San Francisco | CA | 2 - 10 | 2022 | $57,000,000 |
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics. | Cambridge | MA | 20 - 50 | 2022 | $75,000,000 |
Reimagining the IVF lab to increase by 10X the number of families who can be helped. | New York | NY | 20 - 50 | 2022 | $20,000,000 |
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022. | Plymouth | MA | 20 - 50 | 2022 | $242,000,000 |
EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology. | San Mateo | CA | 20 - 50 | 2022 | $96,050,000 |
Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells. They are developing a new generation of AI for drug development by leveraging knowledge-primed models and cancer biology. Their technique makes it poss | New York | NY | 2 - 10 | 2022 | $500,000 |
Forward Therapeutics is a biopharmaceutical company dedicated to transforming the treatment of chronic inflammatory disorders. Forward Therapeutics is advancing a pipeline of novel, next-generation small molecule immune therapies. | Palm Beach Gardens | FL | 2 - 10 | 2022 | $50,000,000 |
Marea Therapeutics is a clinical-stage biotechnology firm that uses the most recent advancements in human genetics to create first-in-class, next-generation medications for cardiometabolic illnesses. | San Francisco | CA | 5 - 10 | 2022 | $255,418,624 |
Developing extended-release PLG drug formulations takes $10M+ and 5-10 years. We enable drug manufacturers and CROs to shorten formulation discovery time by 30-50% by utilizing our automation and machine learning platform. | Woodland | CA | 5 - 20 | 2022 | $4,500,000 |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients. | New York | NY | 2 - 10 | 2022 | $500,000 |
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer | New York | NY | 5 - 20 | 2022 | $30,000,000 |
Bayspair Inc., a Delaware c-corporation, is a startup research and development life science/biotechnology company offering the most flexible genome editing solution in various fields such as agriculture, therapeutics and drug discovery. | Mountain View | CA | 1 - 10 | 2022 | $3,514,000 |
Bluestem Biosciences, Inc., is designing biology with the end in mind, to enable existing infrastructure in the Midwest for industrialized synthetic biology. We are leveraging digital biology to facilitate the discovery of biomanufacturing, focused on the | Omaha | NE | 5 - 20 | 2022 | $10,199,722 |
Terragia Biofuel provides the technology to drive the next generation of biofuels. | Hanover | NH | 5 - 20 | 2022 | $6,000,000 |
TorMagnus Pharmaceuticals combines graph theory and network medicine approaches to use AI to aid in the identification of novel drug treatments. The immediate focus is on identifying targets for Parkinson's disease. | San Francisco | CA | 2 - 10 | 2022 | $500,000 |
CorriXR Therapeutics is a biotechnology company. The company is headquartered in Wilmington, Delaware, United States. | Wilmington | DE | 10 - 50 | 2022 | $6,525,179 |
Sunstone Therapies focuses on the research and commercial delivery of psychedelic therapies for cancer patients. The company was founded in 2022 and is headquartered in Rockville, Maryland. | Rockville | MD | 10 - 50 | 2022 | $8,494,991 |
Santa Ana Bio is a biotechnology company that leverages deep cell profiling technologies to design precision biologics in the autoimmune space.The company was founded in 2021 and is headquartered in Alameda, California. | San Francisco | CA | 20 - 50 | 2022 | $176,024,656 |
Mekanistic Therapeutics focuse on the development of cancer therapeutics. | Ann Arbor | MI | 5 - 10 | 2022 | |
āshibio creates treatments for rare bone and connective tissue ailments, potentially preventing symptoms or slowing their course. | Brisbane | CA | 1 - 10 | 2022 | $40,000,000 |
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | San Francisco | CA | 20 - 50 | 2022 | $47,000,000 |
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. | San Francisco | CA | 5 - 10 | 2022 | $12,000,000 |
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. | Littleton | CO | 10 - 50 | 2022 | $60,000,000 |
Vetmab Biosciences is a veterinary company that currently operates in stealth mode. | San Francisco | CA | 2 - 10 | 2022 | |
Noriware created a seaweed-based packaging film that is entirely composed of natural materials. The raw material seaweed's growth has a negative carbon footprint, with the final product being home-compostable in a revolutionary time frame and thus leaving | Sweden | SC | 2 - 10 | 2022 | 1116135 CHF |
Guardian Bio is centred on developing a personalised cell therapy based on dendritic cells. | Boston | MA | 2 - 10 | 2022 | $500,000 |
Systemic Bio is a 3D Systems company based in Houston, Texas, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development. | Houston | TX | 10 - 50 | 2022 | $15,000,000 |
Aether Therapeutics is a biotechnology compound that develops pharmaceutical compound to treat addiction and withdrawal symptoms. | Austin | TX | 2 - 10 | 2022 | $4,078,010 |
BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most imp | Fishers | IN | 20 - 50 | 2022 | $48,500,000 |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable | New York | NY | 1 - 10 | 2022 | $16,000,000 |
Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public he | Gaithersburg | MD | 5 - 10 | 2022 | $2,000,000 |
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures. | Englewood | CO | 2 - 10 | 2022 | $1,590,329 |
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software | 10 - 20 | 2022 | $15,000,000 | ||
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies. | Seattle | WA | 20 - 50 | 2022 | $85,000,000 |
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. | Tarrytown | NY | 5 - 10 | 2022 | |
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases. Its drug development engine delivers superior biologics optimized to create T-cell engagement by leveraging two technologies that power a pi | Philadelphia | PA | 10 - 50 | 2022 | $165,000,000 |
Arkea Bio develops technology to cut greenhouse gas (GHG) emissions from the agricultural industry. | Charlestown | MA | 10 - 20 | 2022 | $38,500,000 |
Maverick BioMetals is a biotechnology business that is working to improve lithium processing. Founded in 2022 and is based in San Francisco, CA. | San Francisco | CA | 5 - 10 | 2022 | $10,143,534 |
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. | San Francisco | CA | 10 - 50 | 2022 | $94,000,000 |
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles | Cambridge | MA | 10 - 50 | 2022 | $128,000,000 |
Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments to rare diseases and empowering patient communities with unprecedented ownership over the process.Join us | Boston | MA | 10 - 50 | 2022 | $12,000,000 |
Lavo Life Sciences is an early-stage startup that creates drug development software tools. Lavo Life Sciences' AI-accelerated quantum chemistry methods make pharmaceutical property prediction less expensive and more robust than existing solutions. | San Francisco | CA | 2 - 10 | 2022 | $500,000 |
Izote Biosciences is a software company currently based in Berkeley, California, United States. It has been founded in 2022 by Victor Reyes-Umana. | Berkeley | CA | 2 - 10 | 2022 | $2,600,000 |
Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing ”off-the-shelf” allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical grade cells at scale. | New York | NY | 2 - 10 | 2022 | $1,375,000 |
Many diseases, including cancer and monogenic diseases, are often caused by specific proteins that are abnormally degraded and lost from the cell. In cancer, protective tumor suppressors are aberrantly destroyed, allowing cancer cells to circumvent cell de | San Francisco | CA | 20 - 50 | 2022 | $65,000,000 |
Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology. | Boston | MA | 10 - 50 | 2022 | $25,000,000 |
Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics. Cisterna Biologics uses proprietary technologies to build the next generation of mRNA. | Carlsbad | CA | 1 - 10 | 2022 | $500,000 |
Eugit Therapeutics is a therapeutics company that is working to create immunotherapies for the treatment of prostate, ovarian, and breast malignancies. Their gene engineering strategy begins with gamma delta T cells taken from healthy donors and develops a | San Carlos | CA | 2 - 10 | 2022 | $500,000 |
Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability. | Milton | MA | 5 - 20 | 2022 | $15,372,179 |
Septerna's mission is to make the promise of future GPCR medicines a reality for patients. | San Francisco | CA | 20 - 100 | 2022 | $250,000,000 |
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented | Boston | MA | 5 - 20 | 2022 | $153,000,000 |
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | South San Francisco | CA | 5 - 20 | 2022 | $40,000,000 |
FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products. | Cambridge | MA | 2 - 10 | 2022 | $3,413,246 |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | Chapel Hill | NC | 10 - 50 | 2022 | $425,000,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.